What's new

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Jun 6, 2025 - 09:40
 0
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised
Human medicines European public assessment report (EPAR): Eydenzelt, aflibercept, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised
Read More

Tags:

Previous Article

EMEA-003528-PIP01-23

Next Article

Opinion/decision on a Paediatric investigation plan (PIP): Piqray, Alpelisib, de...

Related Posts

EMEA-000639-PIP03-16-M03

EMEA-000639-PIP03-16-M03

May 15, 2025  0

Records of data processing activity for the Organisatio...

May 19, 2025  0

Human medicines European public assessment report (EPAR): Imfinzi, durvalumab, Date of authorisation: 21/09/2018, Revision: 25, Status: Authorised

Human medicines European public assessment report (EPAR...

May 16, 2025  0